Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Search results for: herpes zoster

Pricey Arthritis Drug Effective in Small Fraction of Ulcerative Colitis Cases

Gene Emery  |  May 9, 2017

NEW YORK (Reuters Health)—Pfizer’s expensive arthritis drug tofacitinib has been shown to produce a remission in nearly 1 in 5 patients with moderate to severe ulcerative colitis, but long-term remission persists in fewer than half of those cases. In a series of studies published in the May 4 New England Journal of Medicine, researchers reported…

Filed under:Biologics/DMARDsDrug Updates Tagged with:Tofacitinibulcerative colitis

Rheumatology Practices Need Sharp Focus on Patient Care Safety, Quality

Carina Stanton  |  February 16, 2017

“It is not necessary to change. Survival is not mandatory.” —W. Edwards Deming For practices to survive, change is a requirement—not an option—in the rapidly evolving practice of rheumatology care. Pharmaceutical therapies are advancing quickly, opening the door for game-changing therapies in the treatment of chronic autoimmune disorders. With these advances comes a need for…

Filed under:Practice Support Tagged with:chronic autoimmune disorderpatient carePractice ManagementQualityrheumatologistrheumatologySafetytherapy

Shingles Vaccination Not at Goal Levels for U.S. Seniors

Madeline Kennedy  |  November 28, 2016

(Reuters Health)—Just one in five people over age 60 in the U.S. have been vaccinated against a painful eruption of herpes zoster (shingles), despite recommendations that all of them should get the shot. It’s estimated that among people over age 50, one in three will eventually develop shingles. After age 80, half of adults have…

Filed under:Conditions Tagged with:CDCelderlyherpes zostershinglesvaccinationvaccine

Tips on Vaccinating Patients with Rheumatic Diseases

Thomas R. Collins  |  June 13, 2016

CHICAGO—In October of last year, a 52-year-old woman came to see Kevin Winthrop, MD, MPH, associate professor in infectious diseases, public health and preventive medicine at the Oregon Health & Sciences University. She had rheumatoid arthritis and was taking methotrexate and prednisone. She had had little change in her RA disease severity and was considering…

Filed under:ConditionsPractice Support Tagged with:2016 State-of-the-Art Clinical SymposiumFluherpes zosterpatient carepneumoniaRheumatic Diseaserheumatology

Scleritis Often Diagnosed by Ophthalmologists, But Rheumatologists Help Determine Systemic Causes

Vanessa Caceres  |  March 15, 2016

Ophthalmologists may be more likely to initially diagnose and treat scleritis, an inflammation of the scleral tissues of the eye. However, rheumatologists need to remain aware of the condition as well: It’s commonly associated with rheumatic disorders, such as rheumatoid arthritis (RA). Scleritis can present in the eye anteriorly or posteriorly. “Anterior scleritis can be…

Filed under:ConditionsOther Rheumatic Conditions Tagged with:CauseDiagnosiseyeinflammationophthamologistpatient careRheumatic Diseaserheumatologistscleritissymptom

New SLE Drug May Allow Patients to Reduce Steroid Use

Michele B. Kaufman, PharmD, BCGP  |  December 16, 2015

In a recent study, the use of anifrolumab in SLE patients was shown to be safe and effective, enabling some patients to decrease their oral steroids. Also, secukinumab has been approved in Europe to treat ankylosing spondylitis and psoriatic arthritis…

Filed under:Axial SpondyloarthritisBiologics/DMARDsConditionsDrug UpdatesPsoriatic Arthritis Tagged with:anifrolumabAnkylosing SpondylitisEuropePsoriatic Arthritissecukinumabsystemic lupus erythematosus (SLE)

Biosimilar for Infliximab Launched in Europe

Michele B. Kaufman, PharmD, BCGP  |  April 1, 2015

Plus, updates on arhalofenate, ALO-02, and other rheumatology drug news, safety information

Filed under:Biologics/DMARDsDrug Updates Tagged with:BiosimilarsDrugsFDAinfliximabKaufmanrheumatologySafety

Certolizumab Pegol Drug Studies Find No New Safety Issues

Michele B. Kaufman, PharmD, BCGP  |  March 1, 2015

Plus, updates on clazakizumab, hydrocodone bitartrate extended-release capsules and other rheumatology drug news, safety information

Filed under:Drug Updates Tagged with:Certolizumab PegolclazakizumabdrugFDAhydrocodone bitartrateKaufmanrheumatologySafety

2014 ACR/ARHP Annual Meeting: Patient-Centered Outcomes Research Gaining Support

Kathy Holliman  |  January 1, 2015

Patient Centered Outcomes Research Institute executives review PCORI’s funding, research focus and the importance of including patients as partners

Filed under:Meeting ReportsResearch Rheum Tagged with:2014 ACR/ARHP Annual MeetingFundingHollimanoutcomepatient carePCORIResearchrheumatology

The Science of Chronic Itch

Shivani V. Tripathi, MD, & Brian S. Kim, MD, MTR  |  December 1, 2014

Inside the pathophysiology, clinical presentations of chronic pruritus

Filed under:ConditionsEducation & TrainingMyositisProfessional TopicsResearch Rheum Tagged with:chronic pruritusitchKimmyositispathophysiologypatient careResearchrheumatology

  • « Previous Page
  • 1
  • …
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • Next Page »
  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences